Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced preparation method for 4,4'-diaminobenzenesulphonamide via chlorosulfonation. Delivers high-purity dye intermediates with optimized yield and cost efficiency.
This novel alkaline hydrolysis route for 4-trifluoromethyl nicotinamide synthesis ensures enhanced safety and high purity for global pharmaceutical supply chains and cost reduction.
Novel triiodo-benzene synthesis reduces osmotic pressure. Reliable pharmaceutical intermediate supplier offering cost-effective scaling.
Patent CN107586268B reveals a high-yield route for Erexib intermediates using condensing agents, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN103562196A reveals a novel reductive amination route for Dronedarone intermediates, offering high purity and scalable API manufacturing solutions.
Advanced preparation method for Roflumilast intermediate ensuring high purity and scalable production for global pharmaceutical supply chains.
Novel patent CN106957239A offers low-cost Lacosamide synthesis. High yield, mild conditions, scalable for reliable pharmaceutical intermediate supply chains.
Patent CN112047865B details a green aqueous synthesis of N-alkylsulfonamides using Cp*Ir catalysts, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel patent CN120309586A details high-yield S-hynic synthesis. Offers cost reduction and supply chain reliability for bioconjugate manufacturing.
Patent CN101558056A details a selective halogenation process for anthranilamide intermediates, offering improved yield and scalability for pest control agent manufacturing.
Discover CN101863805B technology for synthesizing chiral sulfinamide catalysts. Enables cost-effective, scalable production of high-purity pharmaceutical intermediates with superior enantioselectivity.
Patent CN108752155A introduces a green CuCl-catalyzed route for N-aryl formamides, offering cost reduction and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN118530145A details a safer route for Darunavir intermediates. High purity above 98 percent ensures supply chain stability and significant cost reduction in API intermediate manufacturing processes.
Patent CN112300061B details a novel Ru-catalyzed C-H acylation method using amides, offering a cost-effective and scalable route for high-purity pharmaceutical intermediates.
Patent CN118290361B details a one-pot method for high-purity phenothiazine derivatives offering reduced waste and improved yield for pharmaceutical intermediate manufacturing supply chains.
Patent CN107382990B reveals a novel 3-step synthesis for potent AChE inhibitors. Discover cost-effective manufacturing strategies for this pharmaceutical intermediate.
Patent CN114456088A details a novel ethanol-based purification for Etoricin, removing amide impurities to ensure high-purity UV absorber manufacturing and supply chain stability.
Novel Boc-protection method for high-purity rhodamine B derivatives. Optimized for scalable fluorescent probe manufacturing and cost-effective supply chain solutions.
Patent CN1915982A details an optimized Ranolazine synthesis route featuring improved yield and purity through refined crystallization and solvent management strategies.
Patent CN1915982A details an optimized Ranolazine synthesis improving yield and purity via refined solvent systems and crystallization protocols for cost-effective manufacturing.